Page 19 - Q2 Results

Shriram Finance Q2 profit rises 7% to ₹2,314 cr, asset quality improves

Shriram Finance's Q2 FY26 profit rose 7 per cent year-on-year to Rs 2,314 crore as total income surged 18 per cent and NPAs declined; the firm expects up to 20 per cent loan growth

Patanjali Foods Q2 results: Profit jumps 67% to ₹516.69 cr, income up 21%

Patanjali Foods Ltd, which is mainly into edible oils, on Friday reported a 67 per cent increase in its consolidated net profit to Rs 516.69 crore for the second quarter of this financial year. Its net profit stood at Rs 308.58 crore in the year-ago period. Total income rose to Rs 9,850.06 crore during the July-September period of 2025-26 fiscal from Rs 8,132.76 crore in the corresponding period of the preceding year, according to a regulatory filing. During the 2024-25 fiscal, the company posted a net profit of Rs 1,300.7 crore over a total income of Rs 33,924.34 crore.

Dr Lal PathLabs Q2 results: PAT up 16.4% at ₹152 crore, revenue rises 11%

Diagnostics chain declares ₹7 per share interim dividend, 1:1 bonus issue

Shriram Finance Q2 results: PAT up 7% to ₹2,314 cr, asset quality improves

Shriram Finance Ltd, the flagship company of diversified conglomerate Shriram Group, on Friday reported a 7 per cent increase in consolidated net profit at Rs 2,314 crore in the second quarter of the current fiscal year. The NBFC firm had earned a consolidated net profit of Rs 2,153 crore in the second quarter of the previous fiscal. Total income rose to Rs 11,921 crore in the quarter under review, from Rs 10,097 crore in the same period a year ago, Shriram Finance said in a regulatory filing. The NBFC firm earned an interest income of Rs 11,551 crore in the quarter as against Rs 9,815 crore in the same period a year ago. Total expenses also moved up to Rs 8,808 crore, as compared to Rs 7,345 crore in the same period in the previous fiscal. The company's asset quality improved with gross Non-Performing Assets (NPAs) declining to 4.57 per cent of gross advances as of September 30, 2025, from 5.32 per cent by the end of the second quarter of the previous fiscal. Net NPAs also moder

LT Foods Q2 results: Profit up 9% to ₹163.85 crore, revenue jumps 30%

FMCG firm LT Foods has reported a consolidated net profit of Rs 163.85 crore in the second quarter ended September, up nearly 9 per cent on a year-on-year basis, driven by higher revenue. The company had reported a net profit of Rs 150.61 crore in the corresponding quarter a year ago, a regulatory filing on Thursday showed. During the quarter under review, LT Foods' total income rose to Rs 2,772.48 crore, from Rs 2,134.04 crore in the previous financial year. Its total expenses, however, also increased to Rs 2,544.19 crore, from Rs 1,942.92 crore, the filing showed. Ashwani Arora, Managing Director & CEO, LT Foods, said, "As we look ahead in FY26, our priority is to build a stronger, future-ready LT Foods -- one that deepens brand equity, accelerates market expansion, invests in digital transformation, and evolves through strategic partnerships. We remain steadfast in delivering products that embody trust, quality, and value for our consumers across the globe.

Maruti Suzuki Q2FY26 results: Profit up 8% at ₹3,349 cr, revenue jumps 13%

On a sequential basis, Maruti Suzuki's profit dropped 11.7 per cent from ₹3,792.4 crore on the back of increased expenses, the company said in a BSE filing

Stock Market close highlights: Sensex sheds 467 points, Nifty at 25,722; SMIDs dip; PSBs outperform

Sensex Today | Stock Market close: Barring Nifty PSU Bank and Nifty Oil & Gas, all other sectoral indices on the NSE settled lower

Bajaj Electricals Q2 results: Profit drops 24% on JV losses, higher taxes

Shares of the company reversed course to trade 0.6% lower after the results

Strides Pharma spurts 15%, hits all-time high on strong Q2 performance

Strides Pharma business outlook, in Q2 earnings update the company said the expansion of product portfolio and new customer acquisitions to drive growth.

Strides Pharma Q2FY26 results: Net profit jumps 82% to ₹131.5 crore

Strides Pharma Science Ltd on Friday reported an 82 per cent jump in consolidated net profit at Rs 131.52 crore in the second quarter ended September 30, 2025 on the back of strong revenue growth in 'other regulated markets' and lower expenses. The company had posted a consolidated net profit of Rs 72.3 crore in the corresponding period last fiscal, Strides Pharma Science said in a regulatory filing. Consolidated revenue from operations in the second quarter stood at Rs 1,220.83 crore as compared to Rs 1,166.93 crore in the year-ago period, it added. Total expenses in the quarter under review stood at Rs 1,085.03 crore as compared to Rs 1,104.61 crore in the same period last fiscal, the company said. Commenting on the performance, Strides Pharma Science MD & Group CEO, Badree Komandur said, "Strides continues to deliver a strong performance in Q2FY26, with growth primarily driven by the 'other regulated markets'." In an investor presentation, the company said in Q2 FY26 'other ...

DLF Q2 results: Sales bookings double to ₹15,757 cr in H1 on high demand

Realty major DLF Ltd's sales bookings more than doubled to Rs 15,757 crore during the first six months of this fiscal year on high demand for its luxury housing projects in Gurugram and Mumbai. According to its latest investors presentation, DLF has reported sales bookings or pre-sales at Rs 15,757 crore during April-September period of this fiscal as against Rs 7,094 crore in the corresponding period of the preceding year. During the 2024-25 financial year, DLF Ltd achieved a record sales bookings of Rs 21,223 crore. The company has given a guidance of achieving sales bookings of Rs 20,000-22,000 crore during the current fiscal year. On Thursday, DLF reported a 15 per cent decline in consolidated net profit at Rs 1,180.09 crore for the second quarter of this fiscal year. Its net profit stood at Rs 1,381.22 crore in the year-ago period. Revenue from operations fell to Rs 1,643.04 crore during the July-September period of this fiscal year from Rs 1,975.02 crore a year ago. Total

ACC Ltd Q2FY26 results: Net profit up over five fold at ₹1,119 crore

Cement maker ACC Ltd on Friday reported more than five-fold rise in consolidated profit after tax (PAT) to Rs 1,119.26 crore in the September quarter on the back of strong sales. The company had posted a consolidated net profit of Rs 199.7 crore in the same period last fiscal year, ACC Ltd said in a regulatory filing. Consolidated revenue from operations in the September quarter stood at Rs 5,896.16 crore as against Rs 4,542.23 crore in the corresponding period last fiscal year, it added. Total expenses in the quarter under review stood at Rs 5,393.42 crore as against Rs 4,473.67 crore in the same period a year ago, the company said. In the second quarter, cement and ancillary services clocked revenue of Rs 5,519.18 crore, up from Rs 4,373.41 crore in the year-ago period, the filing said. Ready mix concrete segment posted revenue of Rs 453.62 crore as against Rs 289.1 crore in the same period last fiscal year, the company said.

Mphasis Q2FY26 results: PAT rises 10.8% to ₹469 cr; revenue at ₹ 3,902 cr

IT solutions provider Mphasis on Friday reported a 10.79 per cent increase in consolidated net profit to Rs 469 crore for the July-September quarter. The company had reported a net profit (attributable to equity owners of the company) of Rs 423.3 crore in the year-ago period, according to regulatory filings. The Bengaluru-headquartered company's revenue from operations rose 10.34 per cent to Rs 3,901.91 crore in Q2 FY26, as against Rs 3,536.14 crore in Q2 FY25. Seen sequentially, profit and revenue rose by 6.18 per cent and 4.53 per cent, respectively. Our early, focused investments in AI have positioned Mphasis as a strategic partner for clients navigating their transformation journey. Another strong quarter of total contract value (TCV) wins of USD 528 million is a testimony to our AI first approach delivering business outcomes, across diverse industries., said Nitin Rakesh, Chief Executive Officer and Managing Director, Mphasis. As much as 87 per cent of the deal wins were in

IDBI Bank hits 52-week high; stock rallies 9% on heavy volumes

The average trading volumes at the IDBI Bank counter jumped nearly two-fold with a combined 58.94 million equity shares changing hands on the NSE and BSE till 12:26 PM.

TD Power zooms 162% from March low; what's driving smallcap stock?

Shares of TD Power Systems hit a new high of ₹768.45, surging 12 per cent on the BSE in Friday's intra-day trade amid heavy volumes in an otherwise weak market.

Weak Q2 performance drags Bandhan Bank shares down 6%; buy, sell or hold?

Bandhan Bank's share price declined after the private lender reported a weak set of numbers for the September quarter of FY26 (Q2FY26).

BSE PSU index hits 52-week high; BHEL, CPCL, MRPL rally up to 17% in 1 week

In the past one week, PSU index has outperformed the market by gaining 1.5 per cent, as against 0.4 per cent decline in the BSE Sensex.

Stocks to buy, sell post Q2 results: ITC, Swiggy, NTPC, 4 others in focus

Technical charts suggest that ITC, Adani Power, Dabur India, NTPC and Hyundai Motor India shares can potentially rally up to 26% on the upside; whereas Dabur India and Bandhan Bank can decline by 10%.

Navin Fluorine stock zooms 15%, hits record high; here's why

MOFSL expect momentum to sustain in 2HFY26, supported by the stable pricing environment of refrigerant gases, robust order book pipeline, and higher realizations and volumes.

Cipla Q2 revenue grows, margins squeeze; analysts decode stock strategy

In the Q2FY26, Cipla reported consolidated revenue from operations of ₹7,589 crore, up 8 per cent year-on-year (Y-o-Y) from ₹7,051 crore in the year-ago period